Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Random forest and Shapley Additive exPlanations predict oxytocin targeted effects on brain functional networks involved in salience and sensorimotor processing, in a randomized clinical trial in autism
    Published on 2025-04-02
    1 year ago
  • Abnormal ventromedial-to-dorsolateral hierarchical topography of striatal circuits in cocaine use disorder and its modulations by brain stimulation
    Published on 2025-04-01
    1 year ago
  • Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing
    Published on 2025-03-26
    1 year ago
  • Early-life adversity alters adult nucleus incertus neurons: implications for neuronal mechanisms of increased stress and compulsive behavior vulnerability
    Published on 2025-03-20
    1 year ago
  • Central Med23 deficiency leads to malformation of dentate gyrus and ADHD-like behaviors in mice
    Published on 2025-03-19
    1 year ago
  • Preregistered multi-site preclinical randomized controlled trials: the beginning of a new day in reverse translational science?
    Published on 2025-03-19
    1 year ago
  • Grey matter morphometry in young adult e-cigarette users, tobacco cigarette users & non-using controls
    Published on 2025-03-18
    1 year ago
« Previous 1 … 58 59 60 61 62 … 143 Next »
Journal of Psychopharmacology
  • Alterations of auditory sensory gating in mice with noise-induced tinnitus treated with nicotine and cannabis extract
    Published on 2023-10-14
    3 years ago
  • Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies
    Published on 2023-10-09
    3 years ago
  • Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial
    Published on 2023-09-23
    3 years ago
  • Comparative efficacy of quetiapine by dose and formulation for psychosis in schizophrenia: A systematic review and dose–response model-based network meta-analysis
    Published on 2023-09-23
    3 years ago
  • Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study
    Published on 2023-09-19
    3 years ago
  • Predicting clozapine dose required to achieve a therapeutic plasma concentration – A comparison of a population algorithm and three algorithms based on gene variant models
    Published on 2023-09-12
    3 years ago
  • Psilocybin history, action and reaction: A narrative clinical review
    Published on 2023-08-31
    3 years ago
« Previous 1 … 58 59 60 61 62 … 150 Next »
European Neuropsychopharmacology
  • Awareness of cardiac autonomic dysregulation by antidepressants
    Published on 2023-09-19
    3 years ago
  • Association of polygenic risk for bipolar disorder with resting-state network functional connectivity in youth with and without bipolar disorder
    Published on 2023-09-16
    3 years ago
  • Psychomotor slowing in schizophrenia is associated with cortical thinning of primary motor cortex: A three cohort structural magnetic resonance imaging study
    Published on 2023-09-16
    3 years ago
  • Is it stress or is it the hormones? Perinatal depression in fathers
    Published on 2023-09-12
    3 years ago
  • A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity in healthy young men
    Published on 2023-09-04
    3 years ago
  • Exploring the potential of Esketamine in the treatment of bipolar depression
    Published on 2023-09-04
    3 years ago
  • The prevalence and correlates of suicidal ideation in Chinese psychiatric patients during the fifth wave of COVID-19 in Hong Kong
    Published on 2023-09-02
    3 years ago
« Previous 1 … 58 59 60 61 62 … 168 Next »

   Pharma Pub